Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Impact of Sponsored Genetic Testing in 170 Consecutive Consenting Patients With Amyotrophic Lateral Sclerosis: A Single-Site Retrospective Review.

Muscle & nerve - 1 Sept 2026

Felice Kevin J, Leighton Dottie B, Daniel Annie S, Cartwright Natalie I, Benchaya Lucas Meira

Abstract excerpt

INTRODUCTION/AIMS: Amyotrophic lateral sclerosis (ALS) is often categorized as sporadic (sALS) or familial (fALS) based on the family history. Several recent genetic studies have found disease-causing variants in 50%-85% of patients with fALS and 10%-15% of those with sALS. The aim of our study is to review our clinical experience with sponsored genetic testing (i.e., pharmaceutical company-sponsored and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Amyotrophic Lateral Sclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C9orf72 Protein

Share to SQSTM1 gene

Share to TBK1 gene

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Superoxide Dismutase-1

Source

Open in PubMed Open full text

Identifiers

PMID: 42324839
DOI: 10.1002/mus.70313
PMCID: PMC13471956

Genes

SOD1
FUS
SQSTM1
TARDBP
TBK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Impact of Sponsored Genetic Testing in 170 Consecutive Consenting Patients With Amyotrophic Lateral Sclerosis: A Single-Site Retrospective Review.PMID 42324839Read ↗

Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic.Semantic proximity Read ↗

Clinical testing panels for ALS: global distribution, consistency, and challengesSemantic proximity Read ↗

Clinical testing panels for ALS: global distribution, consistency, and challenges.Semantic proximity Read ↗

Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication.Semantic proximity Read ↗

Evidence‐based consensus guidelines for ALS genetic testing and counselingSemantic proximity Read ↗

Update and recommendations on genetic testing for amyotrophic lateral sclerosis in clinical practice: a Brazilian expert view.Semantic proximity Read ↗

Incidence of amyotrophic lateral sclerosis-associated genetic variants: a clinic-based study.Semantic proximity Read ↗

Genetic variability in sporadic amyotrophic lateral sclerosis.Semantic proximity Read ↗

The impact of age on genetic testing decisions in amyotrophic lateral sclerosisSemantic proximity Read ↗

Presymptomatic ALS genetic counseling and testingSemantic proximity Read ↗

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic VariantsSemantic proximity Read ↗

Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.